SEC EDGAR · company profile · free

GILEAD SCIENCES, INC. due diligence

Who GILEAD SCIENCES, INC. (GILD) is on the public record: identity, industry classification and the most recent periodic filings, straight from SEC EDGAR.

1000 filings in EDGAR's recent index, 561 of them Form 4 insider filings · view the filings on SEC EDGAR · source: SEC EDGAR submissions index
CIK
0000882095
Industry (SIC)
Biological Products, (No Diagnostic Substances) (2836)
Incorporated
DE
Listed on
Nasdaq
Tickers
GILD
Fiscal year end
12-31
FilingFiledPeriodAccession
Annual report (10-K)2026-02-242025-12-310000882095-26-000006
Quarterly report (10-Q)2026-08-062026-06-300000882095-26-000031
Current report (8-K)2026-08-042026-08-040000882095-26-000028

The full due-diligence dossier on GILEAD SCIENCES, INC.

The free view above is identity and filing dates. The paid dossier reads the filings: business and segments, financial trend, insider and institutional activity, litigation and risk-factor themes, recent news, and the red flags, every claim cited and delivered with a data appendix.

agents: POST /v1/dossier with {"ticker":"GILD"} over x402 or MPP, $9

Sample output and API docs · all reports

GILD insider filingsAll company profiles13F fund holdingsAll reports

Generated from public SEC EDGAR filings. Filing data is shown as filed. This is information, not investment advice.